Abbott India Ltd
Healthcare | Mid Cap
Abbott India Ltd. demonstrates outstanding financial health, anchored by exceptional profitability and a nearly debt-free balance sheet. The company consistently generates high returns and is growing its revenue and profits at a strong pace, indicating robust market demand and operational strength. Its ability to cover short-term financial needs is also very strong. However, there are some areas of mixed performance in its operational efficiency. While it collects cash from customers very quickly, it is slower at selling its inventory and shows subpar efficiency in using its total capital to generate sales. Additionally, the company distributes a large portion of its earnings as dividends, which, while rewarding for shareholders now, represents a potential risk to dividend sustainability if profits were to decline. Overall, Abbott India is a highly profitable and financially stable company with a bright growth outlook, whose main challenges are centered on improving certain operational efficiencies.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio8.40
- Profitability Ratio10.00
- Efficiency Ratio7.00
- Coverage Ratio6.80
- Solvency Ratio10.00
- Liquidity Ratio9.20
- Peer Assessment
- Management AssessmentStrong
- Risk AssessmentStrong
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthBearish
Abbott India Ltd. demonstrates outstanding financial health, anchored by exceptional profitability and a nearly debt-free balance sheet. The company consistently generates high returns and is growing its revenue and profits at a strong pace, indicating robust market demand and operational strength. Its ability to cover short-term financial needs is also very strong. However, there are some areas of mixed performance in its operational efficiency. While it collects cash from customers very quickly, it is slower at selling its inventory and shows subpar efficiency in using its total capital to generate sales. Additionally, the company distributes a large portion of its earnings as dividends, which, while rewarding for shareholders now, represents a potential risk to dividend sustainability if profits were to decline. Overall, Abbott India is a highly profitable and financially stable company with a bright growth outlook, whose main challenges are centered on improving certain operational efficiencies.
Overall Valuation Score
P/E RATIO (TTM)
35.89
Industry Median
28.62
Mid Cap Median
36.34
P/E RATIO
35.89
P/B RATIO
11.67
Industry Median
3.17
Mid Cap Median
7.64
P/S RATIO
8.44
Industry Median
3.42
Mid Cap Median
6.30
Others
PEG RATIO
0.00
EV/EBITDA RATIO
25.86
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹26215 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company is on an excellent growth trajectory across the board. It has demonstrated strong and consistent growth in its revenues, operating profits, and net income. This comprehensive growth is also reflected in the increasing value for shareholders, as seen in the robust earnings per share growth. The company is also expanding its asset base, indicating investment for future activities. This all-around positive momentum suggests strong market demand and effective corporate strategy.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 14.13 | 8.74 | 9.35 | 9.57 | 8.11 |
| Operating Profit Growth Rate | 18 | 10.85 | 20.48 | 16.66 | 11.62 |
| Earnings Per Share (EPS) Growth | 15.64 | 18.87 | 26.52 | 17.75 | 9.73 |
| Asset Growth Rate | 10 | 7.86 | 13.98 | 13.94 | 9.89 |
| Net Income Growth Rate | 15.63 | 18.77 | 26.55 | 17.74 | 9.76 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company shows a very strong financial profile from a shareholder's perspective, with most metrics being excellent. Key indicators like earnings per share, book value, and dividends per share are all showing robust values and growth, reflecting strong value creation. A notable point of contrast is the investment in new assets (capital expenditures), which is significant. This high level of spending on assets, while vital for future growth, represents a large current use of cash.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 380.48 | 451.9 | 571.9 | 673.33 | 739.05 |
| Cash Earnings Per Share (Cash EPS) | 411.9 | 485.24 | 605.71 | 707.62 | 775.24 |
| Book Value Per Share | 1342.86 | 1518.1 | 1761.43 | 2015.71 | 2273.33 |
| Dividend Per Share (DPS) | 274.39 | 326.16 | 412.67 | 472.6 | 474.75 |
| Capital Expenditures (CapEx) | 44 | 34 | 48 | 52 | 12 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company’s profitability is outstanding across every major metric. It demonstrates an excellent ability to convert revenue into profit at every level, from gross profit down to net profit. The returns it generates on the capital invested by shareholders (ROE) and on its overall capital base (ROCE) are exceptionally high. This top-tier performance indicates a strong competitive advantage, excellent operational management, and superior pricing power in its market.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.78 | 21.24 | 23.63 | 25.32 | 26.21 |
| Return on Capital Employed (ROCE) | 38 | 41 | 46 | 46 | 45 |
| Return on Equity (ROE) | 28.33 | 29.77 | 32.47 | 33.4 | 32.51 |
| Return on Assets (ROA) | 25.76 | 26.47 | 27.98 | 28.65 | 29.1 |
| Operating Margin | 22.12 | 22.55 | 24.84 | 26.45 | 27.31 |
| Net Margin | 16.24 | 17.74 | 20.53 | 22.06 | 22.4 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The company's operational efficiency presents a mixed picture. It is highly effective at generating sales from its fixed assets and collecting payments from customers quickly, which are significant strengths. On the negative side, the company is slower in selling its inventory. Furthermore, its overall efficiency in using its total capital (both debt and equity) to generate revenue is low, which is a notable area of underperformance, suggesting its large capital base isn't being used to its full potential for sales generation.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 18.15 | 22.57 | 26 | 19.07 | 20.93 |
| Inventory Turnover Ratio | 5.54 | 6.3 | 7.04 | 6.37 | 5.59 |
| Receivables Turnover Ratio | 18.29 | 17.68 | 18.39 | 18.34 | 18.68 |
| Days Sales in Inventory Ratio | 65.88 | 57.94 | 51.85 | 57.3 | 65.3 |
| Receivable Days | 19.96 | 20.64 | 19.85 | 19.9 | 19.54 |
| Capital Turnover Ratio | 1.66 | 1.62 | 1.55 | 1.45 | 1.4 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's ability to cover its financial obligations shows two different stories. Its capacity to cover interest payments on its debt is exceptionally high, which is a result of its very low debt levels and signifies no risk from interest expenses. On the other hand, its earnings provide only a narrow cover for the dividends it pays to shareholders. This suggests a high dividend payout policy that could be difficult to sustain if profits were to decline.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 57.84 | 80.62 | 135.83 | 172.55 | 84.16 |
| Equity Dividend Coverage Ratio | 1.37 | 1.37 | 1.37 | 1.41 | 1.54 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company exhibits an exceptionally strong solvency position, indicating a very low risk of long-term financial distress. It relies almost entirely on equity rather than debt to finance its assets. This near-debt-free status makes it highly resilient to economic downturns and interest rate fluctuations. This conservative financial structure means profits are not significantly eroded by interest payments, providing maximum financial stability and independence.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.05 | 0.03 | 0.02 | 0.04 | 0.03 |
| Debt to Equity Ratio | 0.05 | 0.03 | 0.02 | 0.04 | 0.03 |
| Equity Ratio | 0.95 | 0.97 | 0.98 | 0.96 | 0.97 |
| Debt To Asset Ratio | 0.04 | 0.02 | 0.02 | 0.03 | 0.03 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's ability to meet its short-term debts is exceptionally strong, showcasing a significant safety cushion with high levels of liquid assets compared to its liabilities. This points to excellent financial stability and a low risk of short-term cash-flow problems. This is a positive sign of its financial health. A minor point of observation is that the cash generated directly from its main business operations, while sufficient, is not as uniformly strong as its other liquidity indicators, showing some variability.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 3.15 | 3.44 | 3.51 | 3.74 | 3.96 |
| Quick Ratio | 2.6 | 2.92 | 3.07 | 3.15 | 3.35 |
| Cash Ratio | 2.19 | 1.54 | 1.51 | 1.09 | 1.45 |
| Operating Cash Flow Ratio | 0.76 | 0.71 | 0.86 | 0.68 | 0.85 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Abbott India Ltd | 8.68 | 35.89 | Neutral | 1892.00 | 730.39 | 1552.00 |
| 2 | Glaxosmithkline Pharmaceuticals Ltd | 8.38 | 38.14 | Neutral | 1309.00 | 59.73 | 1036.00 |
| 3 | J B Chemicals & Pharmaceuticals Ltd | 8.14 | 49.64 | Overvalued | 1107.00 | 41.98 | 709.00 |
| 4 | Alkem Laboratories Ltd | 8.08 | 27.91 | Neutral | 3005.00 | 182.76 | 2351.00 |
| 5 | Gland Pharma Ltd | 7.91 | 35.27 | Overvalued | 1630.00 | 78.88 | 1027.00 |
| 6 | Lupin Ltd | 7.84 | 20.16 | Neutral | 8816.00 | 139.25 | 5355.00 |
| 7 | Ajanta Pharma Ltd | 7.72 | 36.27 | Neutral | 1395.00 | 75.78 | 1056.00 |
| 8 | Mankind Pharma Ltd | 7.61 | 52.10 | Highly Overvalued | 3617.00 | 49.34 | 1938.00 |
| 9 | Zydus Lifesciences Ltd | 7.60 | 21.38 | Neutral | 8475.00 | 35.38 | 5124.00 |
| 10 | Syngene International Ltd | 7.44 | 56.08 | Overvalued | 918.00 | 7.55 | 317.00 |
| 11 | Emcure Pharmaceuticals Ltd | 7.40 | 36.42 | Neutral | 1865.00 | 38.66 | 941.00 |
| 12 | Laurus Labs Ltd | 7.10 | 85.84 | Neutral | 1778.00 | 13.72 | 890.00 |
| 13 | Glenmark Pharmaceuticals Ltd | 6.36 | 45.87 | Neutral | 4572.00 | -7.12 | 1362.00 |
| 14 | Ipca Laboratories Ltd | 6.33 | 35.26 | Neutral | 1979.00 | 44.64 | 1184.00 |
Management effectiveness is assessed as strong. The company demonstrates outstanding financial performance, characterized by consistent double-digit profit growth and significant, sustained improvement in operating margins. Capital is utilized exceptionally well, with top-tier ROCE and ROE figures and a remarkable negative cash conversion cycle, indicating superior working capital management. Financial prudence is a cornerstone, as the company is virtually debt-free with a net cash position and maintains a generous dividend payout policy. The only notable weakness is a consistent decline in FII shareholding, which is more than offset by the extremely high and stable promoter stake and robust domestic institutional interest. Overall, the data points to a highly effective and shareholder-friendly management team.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Return on Capital Employed (ROCE) | 47.87% | Excellent |
| Compounded Profit Growth (5Y) | 18% | Strong | |
| Cash Conversion Cycle (TTM) | -24 days | Outstanding | |
| Debt to Equity | 0.02 | Very Strong | |
| Promoter Holding | 74.99% | Stable | |
| CONS | FII Shareholding Trend | Declining | Weak |
Financial Performance & Growth
Abbott India's financial performance demonstrates exceptional strength and consistency. The company's profit acceleration has consistently outpaced sales, driven by a significant and steady improvement in operational efficiency. The Operating Profit Margin (OPM) has expanded from an average of 14% between 2015-2017 to a strong 25% in the trailing twelve months (TTM) ending March 2024. This margin expansion has translated into impressive compounded profit growth of 18% over the last five years. While year-over-year sales growth has moderated slightly to 8-9% in recent periods, profit growth remains strong, with the latest annual figure at 26.5%. The financial performance is stable, with no significant volatility in quarterly earnings, reflecting disciplined execution.
| Metric | 2015–2017 (Avg) | 2018–2020 (Avg) | 2021–2023 (Avg) | TTM (Mar 2024) |
|---|---|---|---|---|
| Sales Growth (%) | 12.3% | 12.1% | 10.3% | 9.4% |
| Profit Growth (%) | 15.0% | 30.0% | 17.0% | 26.5% |
| OPM (%) | 14.0% | 16.7% | 22.0% | 25.0% |
Capital Efficiency & Returns
The management's effectiveness in capital allocation and efficiency is outstanding. The Return on Capital Employed (ROCE) has been consistently high and has shown an improving trend, reaching an excellent 46% in March 2024. Similarly, the Return on Equity (ROE) has averaged a remarkable 34% over the last five years. A key highlight of operational excellence is the Cash Conversion Cycle (CCC), which has progressively improved from 74 days in 2015 to a negative 24 days in the latest year. A negative CCC signifies that the company collects cash from customers before it has to pay its suppliers, which is a powerful indicator of superior working capital management and strong bargaining power within its supply chain. This level of capital efficiency is a significant competitive advantage.
| Metric | 2015–2017 (Avg) | 2018–2020 (Avg) | 2021–2023 (Avg) | Mar 2024 |
|---|---|---|---|---|
| ROCE (%) | 37.3% | 37.7% | 38.0% | 46.0% |
| ROE (5Y Avg) | 34% | |||
| Cash Conversion Cycle (Days) | 52 | 25 | -1 | -24 |
Financial Health & Prudence
The company's financial health is exceptionally robust. Abbott India is virtually debt-free, with borrowings on its balance sheet being negligible and primarily related to lease liabilities. As of March 2024, the debt-to-equity ratio stood at a minimal 0.02. This strong balance sheet is further supported by a significant net cash position, as cash and equivalents (₹2,134 Cr) far exceed total borrowings. The Interest Coverage Ratio is extremely comfortable at over 135 times, indicating no risk in servicing its minor interest obligations. Management has also maintained a high and consistent Dividend Payout Ratio, which has averaged over 70% in recent years. This combination of a pristine balance sheet and a shareholder-friendly dividend policy underscores strong financial discipline.
| Metric | 2018 | 2020 | 2022 | Mar 2024 |
|---|---|---|---|---|
| Debt to Equity | 0.00 | 0.07 | 0.05 | 0.02 |
| Interest Coverage Ratio | 155x | 89x | 57x | 135x |
| Dividend Payout (%) | 29% | 90% | 73% | 73% |
Shareholding & Ownership Structure
The ownership structure reflects strong promoter conviction but shows a divergence in institutional interest. The promoter holding is a significant strength, remaining constant at a very high 74.99% for many years, indicating a deep, long-term commitment. Domestic Institutional Investors (DIIs) have also shown increasing confidence, with their stake growing steadily from 6.14% in 2017 to 8.91% in March 2024. However, a notable weakness is the persistent decline in Foreign Institutional Investor (FII) holding. The FII stake has eroded from 2.74% in March 2017 to a marginal 0.18% by March 2024. While the increase in DII holding provides a partial offset, the near-complete exit of FIIs is a point of concern regarding the company's appeal to foreign capital. Despite this, the formidable promoter stake ensures stability.
| Metric | Mar 2017-2019 (Avg) | Mar 2020-2022 (Avg) | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Promoter Holding (%) | 74.99% | 74.99% | 74.99% | 74.99% |
| DII Holding (%) | 6.6% | 6.4% | 8.6% | 8.9% |
| FII Holding (%) | 2.5% | 1.0% | 0.2% | 0.2% |
The overall risk profile is low. The company exhibits exceptional financial stability with virtually no debt, eliminating credit and interest rate risk on its liabilities. Earnings quality is very high, as confirmed by operating cash flows that consistently track or exceed net profits, indicating that profits are backed by actual cash. There are no apparent accounting red flags; the balance sheet is clean, and exceptional items are minimal. The primary risk identified is not financial or operational but rather a sentiment indicator: the steady decline in FII ownership. However, this is largely mitigated by strong promoter and DII holdings. The company's operational and financial fundamentals are robust.
Accounting Quality
Earnings quality appears high, as evidenced by the Cash Flow from Operations (CFO). For the year ending March 2024, CFO was 1,213 Cr against a Net Profit of 1,201 Cr, indicating strong conversion of profit into cash. The company's Enterprise Value is lower than its Market Cap, reflecting a net cash position on the balance sheet. Furthermore, the use of exceptional items is infrequent and minimal, suggesting transparent and straightforward financial reporting.
Interest Rate Exposure
The company's exposure to interest rate risk is minimal on the liability side. As a virtually debt-free entity, fluctuations in interest rates have no material impact on its financing costs. On the contrary, with substantial cash and equivalents (₹2,134 Cr as of March 2024), the company benefits from higher interest rates through increased 'Other Income' from its treasury operations. The risk from interest rate movements is therefore negligible.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1026158.50Bullish
- SMA 2026109.75Bullish
- SMA 5026176.90Bullish
- EMA 1026153.27Bullish
- EMA 2026140.85Bullish
- EMA 5026173.31Bullish
- DEMA 1026179.23Bullish
- DEMA 2026143.31Bullish
- DEMA 5026068.14Bullish
- TEMA 1026198.43Bullish
- TEMA 2026168.23Bullish
- TEMA 5026144.59Bullish
- MACD6.32Bullish
- ADX12.71Weak Trend
- IndicatorValueSignal
- RSI56.00Neutral
- CCI139.24Overbought
- ROC 9-0.36Bearish
- ROC 141.04Bullish
- ROC 250.57Bullish
- Stoch K46.20Neutral
- Stoch D38.55Neutral
- IndicatorValueSignal
- BB Upper26308.16Neutral
- BB Middle26109.75Neutral
- BB Lower25911.34Neutral
- ATR155.62Low Volatility
- IndicatorValueSignal
- MFI52.97Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1026123.00Bullish
- SMA 2026140.50Bullish
- SMA 5026134.50Bullish
- EMA 1026153.61Bullish
- EMA 2026152.76Bullish
- EMA 5026275.30Bearish
- DEMA 1026175.95Bullish
- DEMA 2026125.33Bullish
- DEMA 5026031.37Bullish
- TEMA 1026210.58Bullish
- TEMA 2026170.82Bullish
- TEMA 5025978.48Bullish
- MACD-15.82Bullish
- ADX16.58Weak Trend
- IndicatorValueSignal
- RSI53.63Neutral
- CCI81.51Neutral
- ROC 91.18Bullish
- ROC 140.86Bullish
- ROC 250.75Bullish
- Stoch K56.05Neutral
- Stoch D48.14Neutral
- IndicatorValueSignal
- BB Upper26352.56Neutral
- BB Middle26140.50Neutral
- BB Lower25928.44Neutral
- ATR219.88Low Volatility
- IndicatorValueSignal
- MFI43.34Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1026142.00Bullish
- SMA 2026167.75Bullish
- SMA 5026773.00Bearish
- EMA 1026167.10Bullish
- EMA 2026230.71Bullish
- EMA 5026432.51Bearish
- DEMA 1026149.06Bullish
- DEMA 2026053.60Bullish
- DEMA 5026345.73Bearish
- TEMA 1026189.21Bullish
- TEMA 2026096.62Bullish
- TEMA 50N/AN/A
- MACD-114.70Bullish
- ADX16.75Weak Trend
- IndicatorValueSignal
- RSI48.83Neutral
- CCI34.47Neutral
- ROC 90.06Bullish
- ROC 14-0.79Bearish
- ROC 250.85Bullish
- Stoch K43.38Neutral
- Stoch D38.96Neutral
- IndicatorValueSignal
- BB Upper26503.63Neutral
- BB Middle26167.75Neutral
- BB Lower25831.87Neutral
- ATR359.09Low Volatility
- IndicatorValueSignal
- MFI60.28Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 1026135.50Bullish
- SMA 2026518.50Bearish
- SMA 5026369.70Bearish
- SMA 10026578.25Bearish
- SMA 20028037.15Bearish
- EMA 1026211.29Bullish
- EMA 2026376.19Bearish
- EMA 5026514.55Bearish
- EMA 10026891.19Bearish
- EMA 20027741.77Bearish
- DEMA 1026041.74Bullish
- DEMA 2026167.46Bullish
- DEMA 5026306.44Bearish
- DEMA 10025938.74Bullish
- DEMA 20026518.76Bearish
- TEMA 1026088.48Bullish
- TEMA 2025964.77Bullish
- TEMA 5026484.12Bearish
- TEMA 10026087.51Bullish
- TEMA 20025437.02Bullish
- MACD-174.96Bearish
- ADX20.63Weak Trend
- IndicatorValueSignal
- RSI46.51Neutral
- CCI-43.77Neutral
- ROC 14-2.33Bearish
- ROC 25-4.74Bearish
- Stoch K31.40Neutral
- Stoch D24.22Neutral
- IndicatorValueSignal
- BB Upper27831.22Neutral
- BB Middle26518.50Neutral
- BB Lower25205.78Neutral
- ATR549.81Low Volatility
- IndicatorValueSignal
- MFI45.28Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 2026556.75Bearish
- SMA 5028914.80Bearish
- EMA 2026885.28Bearish
- EMA 5027946.06Bearish
- DEMA 2026068.71Bullish
- DEMA 5027001.08Bearish
- TEMA 2026274.78Bullish
- TEMA 5025686.37Bullish
- MACD-540.66Bullish
- ADX12.64Weak Trend
- IndicatorValueSignal
- RSI43.30Neutral
- CCI-83.83Neutral
- ROC 14-3.82Bearish
- ROC 25-6.26Bearish
- Stoch K37.88Neutral
- Stoch D54.03Neutral
- IndicatorValueSignal
- BB Upper28011.44Neutral
- BB Middle26556.75Neutral
- BB Lower25102.06Neutral
- ATR1227.64Low Volatility
- IndicatorValueSignal
- MFI39.20Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 626887.50Bearish
- SMA 1229270.00Bearish
- SMA 2429199.30Bearish
- EMA 627041.41Bearish
- EMA 1227981.89Bearish
- EMA 2427931.06Bearish
- DEMA 625934.99Bullish
- DEMA 1227048.38Bearish
- DEMA 2429349.59Bearish
- TEMA 625822.13Bullish
- TEMA 1225732.93Bullish
- TEMA 2427810.29Bearish
- MACD2773.15Bearish
- ADX23.58Weak Trend
- IndicatorValueSignal
- RSI53.52Neutral
- CCI22.99Neutral
- ROC 251.55Bullish
- ROC 5051.70Bullish
- Stoch K43.31Neutral
- Stoch D70.35Neutral
- IndicatorValueSignal
- BB Upper34423.91Neutral
- BB Middle29270.63Neutral
- BB Lower24117.35Neutral
- ATR2795.79High Volatility
- IndicatorValueSignal
- MFI43.20Neutral